ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,914Medicare Part D Prescriptions Filled, Including Refills

Rank: 82 out of 680

$1.41M Total Retail Price of All Prescriptions

Rank: 28 out of 680

622 Patients Receiving at Least One Drug in Part D
59%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 622 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

16% of this provider’s 622 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 9,663 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
SIMVASTATIN 498 325 1 3
LEVOTHYROXINE SODIUM 443 297 2 2
METFORMIN HCL 426 277 3 8
ZOLPIDEM TARTRATE 421 221 4 17
NEXIUM 396 182 5 16
TRAMADOL HCL 379 251 6 18
ATORVASTATIN CALCIUM 346 173 7 11
FUROSEMIDE 338 235 8 6
AMLODIPINE BESYLATE 322 223 9 1
LISINOPRIL 312 197 10 5
GLIMEPIRIDE 308 163 11 29
OMEPRAZOLE 274 169 12 7
CRESTOR 269 124 13 25
HYDROCODONE-ACETAMINOPHEN 229 134 S3 14 4
ALPRAZOLAM 215 141 15 72
LOVAZA 197 51 16 119
HYDROCHLOROTHIAZIDE 191 138 17 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 189 146 18 37
PRAVASTATIN SODIUM 179 129 19 10
METOPROLOL TARTRATE 174 117 20 12
RAMIPRIL 173 103 21 69
METOPROLOL SUCCINATE 172 137 22 13
GABAPENTIN 164 76 23 15
MELOXICAM 159 87 24 24
PANTOPRAZOLE SODIUM 152 107 25 30
POTASSIUM CHLORIDE 149 93 26 14
PROAIR HFA 148 69 27 67
PEN NEEDLE 142 54 28 122
LEVOCETIRIZINE DIHYDROCHLORIDE 141 88 29 216
AMLODIPINE BESYLATE-BENAZEPRIL 141 89 29 43
LEVOFLOXACIN 135 78 31 97
WARFARIN SODIUM 135 118 31 20
TEMAZEPAM 133 93 33 155
CITALOPRAM HBR 131 85 34 22
ATENOLOL 131 116 34 19
LANTUS SOLOSTAR 129 68 36 84
AMOX TR-POTASSIUM CLAVULANATE 126 52 37 124
PAROXETINE HCL 126 34 37 76
ALENDRONATE SODIUM 123 101 39 32
IBUPROFEN 119 30 40 126
DIOVAN HCT 118 50 41 55
CLOPIDOGREL 116 79 42 26
TRIAMTERENE-HCTZ 114 70 43 52
CYMBALTA 107 33 44 46
PLAVIX 104 72 45 39
ADVAIR DISKUS 104 61 45 53
FLUOXETINE HCL 96 41 47 74
FENOFIBRATE 95 58 48 66
CLONAZEPAM 94 52 49 190
KLOR-CON M20 92 62 50 61
PREMARIN 92 28 R 50 105
SINGULAIR 90 36 52 91
TRAZODONE HCL 90 41 52 48
LORAZEPAM 87 86 54 125
INSULIN SYRINGE 86 44 55 86
AMITRIPTYLINE HCL 85 56 R 56 47
FLUTICASONE PROPIONATE 84 43 57 41
SPIRIVA 80 21 58 70
NASONEX 77 34 59 197
LANSOPRAZOLE 73 62 60 184
RANITIDINE HCL 70 42 61 56
JANUVIA 70 45 61 60
ESCITALOPRAM OXALATE 70 37 61 45
DIOVAN 70 37 61 31
COMBIVENT 69 35 65 168
ONGLYZA 68 54 66 136
TOPIRAMATE 67 0 67 233
SERTRALINE HCL 66 41 68 28
PHENYTOIN SODIUM EXTENDED 64 12 69 115
TRICOR 63 12 70 98
LOVASTATIN 62 59 71 44
CARVEDILOL 61 42 72 23
CYCLOBENZAPRINE HCL 61 0 R 72 81
CLONIDINE HCL 59 15 74 36
ONDANSETRON HCL 58 31 75 287
QUETIAPINE FUMARATE 57 14 76 64
TIZANIDINE HCL 57 28 76 140
SYNTHROID 57 14 76 38
SYMBICORT 56 14 79 208
LIPITOR 55 23 80 68
LANTUS 55 37 80 49
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 36 82 94
IBANDRONATE SODIUM 52 27 82 288
CIPROFLOXACIN HCL 52 33 82 57
ROPINIROLE HCL 51 30 85 99
LYRICA 50 22 86 77
NOVOLOG MIX 70-30 FLEXPEN 50 35 86 289
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 4, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.